Restless Legs Syndrome in Patients With Chronic Kidney Disease

被引:67
作者
Novak, Marta [1 ,2 ]
Winkelman, John W. [3 ]
Unruh, Mark [4 ]
机构
[1] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
[2] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary
[3] Massachusetts Gen Hosp, Dept Psychiat, Sleep Disorders Clin Res Program, Boston, MA 02114 USA
[4] Univ New Mexico, Sch Med, Div Nephrol, Albuquerque, NM 87131 USA
关键词
Chronic kidney disease; dialysis; kidney transplantation; quality of life; restless legs syndrome; sleep; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; PERIODIC LIMB MOVEMENTS; DOUBLE-BLIND; HEMODIALYSIS-PATIENTS; GABAPENTIN ENACARBIL; SLEEP DISORDERS; CLINICAL CHARACTERISTICS; CARDIOVASCULAR RISK; DIALYSIS PATIENTS;
D O I
10.1016/j.semnephrol.2015.06.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Symptoms of restless legs syndrome (RLS) are common in patients with chronic kidney disease (CKD) on dialysis; symptoms of RLS are estimated to affect up to 25% of patients on dialysis when the international RLS diagnostic criteria are applied. RLS is a neurologic disorder with a circadian rhythmicity characterized by an overwhelming urge to move the legs during rest, which can be relieved temporarily by movement. RLS has been associated with an increase in sleep disturbance, higher cardiovascular morbidity, decreased quality of life, and an increased risk of death in patients with CKD. Although the exact pathophysiology of RLS is unknown, it is thought to involve an imbalance in iron metabolism and dopamine neurotransmission in the brain. The symptoms of moderate to severe RLS can be treated with several pharmacologic agents; however, data specific to patients on dialysis with RLS are lacking. The purpose of this article is to examine the relationship between, and complications of, RLS and CKD both in dialysis and nondialysis patients, and discuss the treatment options for patients on dialysis with RLS. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码:347 / 358
页数:12
相关论文
共 99 条
  • [11] Quality of sleep and day-time sleepiness in chronic hemodialysis: A study of 400 patients
    Araujo, Sonia M. H. A.
    Bruin, Veralice M. S.
    Daher, Elizabeth Francesco
    Mendes Medeiros, Camila Andrade
    Almeida, Gilson H.
    Bruin, Pedro F. C.
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (05): : 359 - 364
  • [12] Restless Legs Syndrome and Hypertension in Middle-Aged Women
    Batool-Anwar, Salma
    Malhotra, Atul
    Forman, John
    Winkelman, John
    Li, Yanping
    Gao, Xiang
    [J]. HYPERTENSION, 2011, 58 (05) : 791 - 796
  • [13] Diagnosis, comorbidities, and management of restless legs syndrome
    Becker, Philip M.
    Novak, Marta
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1441 - 1460
  • [14] Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics
    Benes, Heike
    Walters, Arthur S.
    Allen, Richard P.
    Hening, Wayne A.
    Kohnen, Ralf
    [J]. MOVEMENT DISORDERS, 2007, 22 : S401 - S408
  • [15] Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study
    Bogan, Richard K.
    Cramer Bornemann, Michel A.
    Kushida, Clete A.
    Tran, Pierre V.
    Barrett, Ronald W.
    [J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 512 - 521
  • [16] Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
    Cawello, Willi
    Ahrweiler, Sascha
    Sulowicz, Wladyslaw
    Szymczakiewicz-Multanowska, Agnieszka
    Braun, Marina
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) : 46 - 54
  • [17] Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis
    Cirignotta, F
    Mondini, S
    Santoro, A
    Ferrari, G
    Gerardi, R
    Buzzi, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) : 302 - 306
  • [18] Clinical and biochemical findings in uremic patients with and without restless legs syndrome
    Collado-Seidel, V
    Kohnen, R
    Samtleben, W
    Hillebrand, GF
    Oertel, WH
    Trenkwalder, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) : 324 - 328
  • [19] XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: II.: Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
    Cundy, KC
    Annamalai, T
    Bu, L
    De Vera, J
    Estrela, J
    Luo, W
    Shirsat, P
    Torneros, A
    Yao, FM
    Zou, J
    Barrett, RW
    Gallop, MA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) : 324 - 333
  • [20] The prevalence and management of chronic pain in end-stage renal disease
    Davison, Sara Nicola
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2007, 10 (06) : 1277 - 1287